In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff
Ana
A
Division of Infectious Diseases, VCU Medical Center, P.O.Box 49, Richmond, Virginia 23298-0049, USA. avingroff@hsc.vcu.edu
D000077612:Anidulafungin; D000935:Antifungal Agents / Q000494:pharmacology*; D054714:Echinocandins; D005658:Fungi / Q000187:drug effects*; D006801:Humans; D055666:Lipopeptides; D008074:Lipoproteins / Q000494:pharmacology*; D000077551:Micafungin; D009172:Mycology / Q000379:methods; D010456:Peptides, Cyclic / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008074:Lipoproteins; D010456:Peptides, Cyclic; D014230:Triazoles; C101425:posaconazole; D000077612:Anidulafungin; D000077551:Micafungin